Do patients treated with lipid-lowering drugs run a coronary risk?;Tienen riesgo coronario los pacientes que tratamos con farmacos hipolipemiantes?

Atencion Primaria

Volumn 20, Issue 1, 1997, Pages 49-53

  Vilaseca Canals, J ^a   Buxeda Mestres, C ^a   Camara Contreras, C ^a   Flor Serra, F ^a   Perez Guinaldo, R ^a   Sanchez Vinas, M ^a  

^a NONE   (Spain)

Author keywords

cardiovascular risk; hypercholesterolaemia; treatment

Indexed keywords

ANTILIPEMIC AGENT; CLOFIBRATE DERIVATIVE; DIETHYLAMINOETHYLDEXTRAN; PROBUCOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

ADULT; AGED; ANTILIPEMIC AGENTS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS; SPAIN;

EID: 0030990470     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)